Literature DB >> 2797027

Improvement of carcinogen identification in BALB/3T3 cell transformation by application of a 2-stage method.

A Sakai1, M Sato.   

Abstract

The present studies intend to heighten the sensitivity of BALB/3T3 cells to chemical carcinogens in a transformation assay, by including exposure of carcinogen-treated cells to a tumor promoter, 12-O-tetradecanoylphorbol 13-acetate (TPA). In the assay, cells were first treated with a known or suspected carcinogen for 72 h, cultured in normal medium for 3 days, exposed to media with and without TPA for 2 weeks, and cultured in normal medium for an additional 3 weeks. Benzo[a]pyrene, a potent carcinogen with a polycyclic aromatic hydrocarbon structure, caused transformation in the presence and absence of TPA. N-Methyl-N'-nitro-N-nitrosoguanidine (MNNG), a carcinogen with direct-acting alkylating ability, did not induce significant transformation without TPA, while treatment with MNNG followed by TPA produced numerous transformed foci, classifying MNNG as an initiating agent of transformation under the condition presented in this report. 3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1), 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide (AF-2), sodium nitrite and butylated hydroxyanisole (BHA), which are carcinogenic and/or mutagenic, produced transformed foci in significant numbers of treated dishes in the presence but not in the absence of TPA. Butylated hydroxytoluene (BHT) and sodium saccharin, which are considered to be a modifier and a promoter of carcinogenesis, did not cause significant transformation with or without TPA treatment. These studies suggest that this 2-stage transformation system is capable of detecting a wider range of chemical carcinogens as initiating agents than the standard assay. Studies on the transformation assay schedule revealed that the proportion of dishes with foci, the number of foci per dish and sizes of foci all increased in the normal medium after the termination of TPA treatment. Therefore, transformed cells appear to proliferate independently of TPA after those cells are released by TPA from postconfluence inhibition of cell division.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797027     DOI: 10.1016/0027-5107(89)90172-3

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Human pancreatic cancer cell exosomes, but not human normal cell exosomes, act as an initiator in cell transformation.

Authors:  Karoliina Stefanius; Kelly Servage; Marcela de Souza Santos; Hillery Fields Gray; Jason E Toombs; Suneeta Chimalapati; Min S Kim; Venkat S Malladi; Rolf Brekken; Kim Orth
Journal:  Elife       Date:  2019-05-28       Impact factor: 8.140

2.  Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needs.

Authors:  Stuart Creton; Marilyn J Aardema; Paul L Carmichael; James S Harvey; Francis L Martin; Robert F Newbold; Michael R O'Donovan; Kamala Pant; Albrecht Poth; Ayako Sakai; Kiyoshi Sasaki; Andrew D Scott; Leonard M Schechtman; Rhine R Shen; Noriho Tanaka; Hemad Yasaei
Journal:  Mutagenesis       Date:  2011-08-17       Impact factor: 3.000

3.  Comparison of In Vitro Cell Transformation Assay Using Murine Fibroblasts and Human Keratinocytes.

Authors:  Jun-Ho Ahn; Sue Nie Park; Yung-Na Yum; Ji-Young Kim; Michael Lee
Journal:  Toxicol Res       Date:  2008-03-01

4.  Proteomic Profiling of Small Extracellular Vesicles Secreted by Human Pancreatic Cancer Cells Implicated in Cellular Transformation.

Authors:  Kelly A Servage; Karoliina Stefanius; Hillery Fields Gray; Kim Orth
Journal:  Sci Rep       Date:  2020-05-07       Impact factor: 4.379

5.  Improvement of the BALB/c-3T3 cell transformation assay: a tool for investigating cancer mechanisms and therapies.

Authors:  Doerte Poburski; René Thierbach
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

6.  1,2-Dibromoethane as an initiating agent for cell transformation.

Authors:  A Colacci; P Perocco; M Vaccari; C Da Vià; P Silingardi; E Manzini; W Horn; S Bartoli; S Grilli
Journal:  Jpn J Cancer Res       Date:  1995-02

7.  Promotion of BALB/3T3 cell transformation by the okadaic acid class of tumor promoters, okadaic acid and dinophysistoxin-1.

Authors:  A Sakai; H Fujiki
Journal:  Jpn J Cancer Res       Date:  1991-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.